| Financial Year |
March 31 2023 |
| Monetary Funds |
12,626,970,682.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
329,113,928.83 |
| Accounts Receivable |
29,715,059,161.68 |
| Advances to Suppliers |
5,620,425,665.24 |
| Other Receivables |
1,287,162,174.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,971,279.66 |
| Inventories |
226,747,744.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
198,035,148.52 |
| Total Current Assets |
50,003,514,504.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,821,793,570.76 |
| Investment Properties |
1,608,580,932.83 |
| Fixed Assetes |
137,807,523,421.23 |
| Under-construction Projects |
34,885,101,113.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,973,978,252.54 |
| R&D expenses |
16,166,622.91 |
| Goodwill |
1,667,193,069.94 |
| Long-Term Deferred and Prepaid Expenses |
177,999,708.07 |
| Deferred Income Tax Assets |
1,897,727,926.42 |
| Other Non-Current Assets |
9,388,587,098.11 |
| Sub-Total of Non-Current Assets |
220,942,954,875.33 |
| Total Assets |
270,946,469,380.22 |
| Short-Term Loans |
1,208,770,260.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,191,934,938.60 |
| Accounts Payable |
22,391,231,824.59 |
| Accounts Received In Advance |
1,248,251.80 |
| Employee Compensation Payable |
91,611,649.56 |
| Taxes Payable |
424,557,572.29 |
| Interest Payable |
-- |
| Dividend Payable |
1,798,310.15 |
| Other payables |
3,085,015,032.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,739,312,892.61 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
41,249,495,700.96 |
| Long-term Loans |
109,355,805,659.40 |
| Bonds Payable |
6,636,220,261.09 |
| Long-Term Accounts Payable |
13,282,251,189.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,810,285,748.96 |
| Other Non-Current Liabilities |
245,136,076.48 |
| Sub-Total of Non-Current Liabilities |
138,663,484,305.26 |
| Total Liabilities |
179,912,980,006.22 |
| Paid-In Capital(Or Share Stock) |
28,624,119,200.00 |
| Capital Surplus |
23,624,856,557.44 |
| Surplus Reserve |
652,327,039.52 |
| LESS:Treasury Stock |
175,464,247.25 |
| Undistributed Profits |
26,323,635,422.03 |
| Minority Stockholder's Interest |
11,692,946,099.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
79,340,543,274.04 |
| Owner's Equity（Stockholder's Equity） |
91,033,489,374.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
270,946,469,380.22 |
